Positive drug control group:Refer to the National Health Office Medical Letter (2020) 77 document "Diagnosis and treatment plan for the novel coronavirus disease (trial version 5)" general treatment p
Sponsors
Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine
Conditions
Novel Coronavirus Pneumonia (COVID-19)
Early Phase 1
Cancelled by the investigator Study for the Effectiveness and Safety of Compound Yuxingcao Mixture in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)
Active, not recruitingITMCTR2000003079
Start: 2020-02-26Updated: 2023-02-20
Cancelled by the investigator Study for the Effectiveness and Safety of Compound Yuxingcao Mixture in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)
Active, not recruitingChiCTR2000030478
Start: 2020-02-26Updated: 2020-03-16